Pharming Group N.V. (PHAR) Q4 2024 Earnings Call Transcript

2025-03-13 19:44:30 ET

Pharming Group N.V. (PHAR)

Q4 2024 Earnings Conference Call

March 13, 2025, 8:30 a.m. ET

Company Participants

Fabrice Chouraqui - CEO

Stephen Toor - CCO

Anurag Relan - Chief Medical Officer

Jeroen Wakkerman - CFO

Conference Call Participants

Jeff Jones – Oppenheimer

Ben Jackson – Jefferies

Alistair Campbell - RBC Capital Markets

Joe Pantginis - H.C. Wainwright

Simon Scholes - First Berlin

Presentation

Operator

Good day and thank you for standing by. Welcome to the Pharming Group Fourth Quarter and Full-year 2024 Results Conference Call and Webcast. [Operator Instructions] Please be advised that today's conference is being recorded. I'd now like to hand the conference over to your first speaker today, Fabrice Chouraqui, CEO. Please go ahead, sir.

Fabrice Chouraqui

Thank you very much. Hello, everyone, and welcome to the Pharming’s full-year and Q4 2024 financial results Call. I'm Fabrice Chouraqui, CEO of Pharming, and I'll be joined on this call today by Stephen Toor, our Chief Commercial Officer, Anurag Relan, our Chief Medical Officer, and Jeroen Wakkerman, our Chief Financial Officer.

We'll be making forward-looking statements in this call that are based upon our current insights and plans. As you know, this may differ from future results....

Read the full article on Seeking Alpha

For further details see: